DRKS00023289尚未招募不适用
Prostate-specific Membrane Antigen (PSMA) expression in cervical carcinoma
niversitätsklinikum FreiburgKlinik für Frauenheilkunde0 个研究点目标入组 100 人开始时间: 2020年10月16日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 0 Years 至 100 Years（—）
- 性别
- Female
入选标准
- •Patients with a histologically secured invasive cervical carcinoma are included in this study . The cancerous pre-stages surrounding the Tumor (cervical intraepithelial neoplasia, adenocarcinoma in situ) are also investigated.
排除标准
- •- no declaration of consent
- •- other oncological disease
- •- adenosquamous, neuroendocrine (large or small cell), clear-line or serous-papillary carcinoma
- •- Cytostatic or radiotherapy administered before tissue sampling
研究者
相似试验
已完成
不适用
Prostate-specific Membrane Antigen (PSMA) expression in endometrial cancerC54Malignant neoplasm of corpus uteriDRKS00025005niversitätsklinikum Freiburg Klinik für Frauenheilkunde61
尚未招募
不适用
Prostate-specific membrane antigen (PSMA) expression in ovarian carcinomaC56Malignant neoplasm of ovaryDRKS00023240niversitätsklinikum Freiburg Klinik für Frauenheilkunde100
招募中
2 期
Prostate-Specific Membrane Antigen (PSMA) Intensity Can be Altered by Androgen and phospho-SrC Obstructiometastatic castration-resistant prostate cancerCancer - ProstateACTRN12621000611820St Vincent's Hospital, Sydney22
招募中
2 期
Expression of prostate specific membrane antigen (PSMA) in soft tissue sarcomas and urothelial cell carcinomas: implications for tumour-specific molecular imaging and treatment?cohort 1: soft tissue cancercohort 2: transitional cell carcinomasoft tissue tumour1002838910004994bladder cancerNL-OMON54064eids Universitair Medisch Centrum120
尚未招募
1 期
Emerging digital imaging-guided theranostic therapy for newly diagnosed high risk prostate cancer patients: A feasibility studyCancer - ProstateProstate CancerACTRN12620001358932I-MED Radiology Network5